Literature DB >> 25240157

Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach.

Szabolcs Fekete1, Alain Beck2, Jenő Fekete3, Davy Guillarme4.   

Abstract

Ion exchange chromatography (IEX) is a historical technique widely used for the detailed characterization of therapeutic proteins and can be considered as a reference and powerful technique for the qualitative and quantitative evaluation of charge variants. When applying salt gradient IEX approach for monoclonal antibodies (mAbs) characterization, this approach is described as time-consuming to develop and product-specific. The goal of this study was to tackle these two bottle-necks. By modeling the retention of several commercial mAbs and their variants in IEX, we proved that the mobile phase temperature was not relevant for tuning selectivity, while optimal salt gradient program can be easily found based on only two initial gradients of different slopes. Last but not least, the dependence of retention vs. pH being polynomial, three initial runs at different pH were required to optimize mobile phase pH. Finally, only 9h of initial experiments were necessary to simultaneously optimize salt gradient profile and pH in IEX. The data can then be treated with commercial modeling software to find out the optimal conditions to be used, and accuracy of retention times prediction was excellent (less than 1% variation between predicted and experimental values). Second, we also proved that generic IEX conditions can be applied for the characterization of mAbs possessing a wide range of pI, from 6.7 to 9.1. For this purpose, a strong cation exchange column has to be employed at a pH below 6 and using a proportion of NaCl up to 0.2M. Under these conditions, all the mAbs were properly eluted from the column. Therefore, salt gradient CEX can be considered as a generic multi-product approach.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cetuximab; Ion exchange; Method development; Monoclonal antibody; Salt gradient

Mesh:

Substances:

Year:  2014        PMID: 25240157     DOI: 10.1016/j.jpba.2014.08.035

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  12 in total

1.  A chemical and computational approach to comprehensive glycation characterization on antibodies.

Authors:  Ramsey A Saleem; Brittany R Affholter; Sihong Deng; Phil C Campbell; Kelli Matthies; Catherine M Eakin; Alison Wallace
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation.

Authors:  Ewald T J van den Bremer; Frank J Beurskens; Marleen Voorhorst; Patrick J Engelberts; Rob N de Jong; Burt G van der Boom; Erika M Cook; Margaret A Lindorfer; Ronald P Taylor; Patrick Hc van Berkel; Paul Whi Parren
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Qualification of NISTmAb charge heterogeneity control assays.

Authors:  Abigail Turner; John E Schiel
Journal:  Anal Bioanal Chem       Date:  2018-02-09       Impact factor: 4.142

4.  Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone.

Authors:  S Melamed-Gal; P Loupe; B Timan; V Weinstein; S Kolitz; J Zhang; J Funt; A Komlosh; N Ashkenazi; O Bar-Ilan; A Konya; O Beriozkin; D Laifenfeld; T Hasson; R Krispin; T Molotsky; G Papir; L Sulimani; B Zeskind; P Liu; S Nock; M R Hayden; A Gilbert; I Grossman
Journal:  eNeurologicalSci       Date:  2018-05-30

5.  Direct measurement of light and heavy antibody chains using ion mobility and middle-down mass spectrometry.

Authors:  Rafael D Melani; Kristina Srzentić; Vincent R Gerbasi; John P McGee; Romain Huguet; Luca Fornelli; Neil L Kelleher
Journal:  MAbs       Date:  2019-10-13       Impact factor: 5.857

6.  LC-MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity.

Authors:  Sumit Kumar Singh; Deepak Kumar; Himanshu Malani; Anurag S Rathore
Journal:  Sci Rep       Date:  2021-01-29       Impact factor: 4.379

7.  A novel twin-column continuous chromatography approach for separation and enrichment of monoclonal antibody charge variants.

Authors:  Shu-Ying Jing; Ce Shi; Hui Yi Leong; Jun-Jie Yuan; Dong Gao; Hai-Bin Wang; Shan-Jing Yao; Dong-Qiang Lin
Journal:  Eng Life Sci       Date:  2021-05-12       Impact factor: 2.678

8.  Coupling Multi Angle Light Scattering to Ion Exchange chromatography (IEX-MALS) for protein characterization.

Authors:  Hadar Amartely; Orly Avraham; Assaf Friedler; Oded Livnah; Mario Lebendiker
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

9.  Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry.

Authors:  Florian Füssl; Anne Trappe; Ken Cook; Kai Scheffler; Oliver Fitzgerald; Jonathan Bones
Journal:  MAbs       Date:  2018-11-11       Impact factor: 5.857

10.  Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies.

Authors:  Fengfei Ma; Fahimeh Raoufi; Marc Andre Bailly; Laurence Fayadat-Dilman; Daniela Tomazela
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.